| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| William Benson Witte | Director | $121K | Dec 15, 2021 | ||
| Gary Thompson | VP, Finance & Administration | $33.2K | Jun 17, 2021 | ||
| Charles Larsen | Director | Jul 12, 2024 | |||
| Dov Elefant | Chief Financial Officer | Feb 1, 2024 | |||
| John Q. Adams JR | Director | Jun 8, 2022 | |||
| John Dyett | Director | Jun 8, 2022 | |||
| Kathy Lee-Sepsick | Chief Executive Officer, Director | Feb 1, 2024 | |||
| Anne Morrissey | Director | Jun 21, 2023 | |||
| Wendy Perrow | Director | Jun 21, 2023 | |||
| Christine E. Thomas | SVP, Regulatory & Clinical | Feb 1, 2024 | |||
| Keith J. Kendall | Director | Jun 14, 2023 | |||
| Hoskin Violet Alexandria Kelley | VP, Clinical & Medical Affairs | Jun 17, 2021 | |||
| Edward Evantash | Chief Medical Officer | Sep 1, 2021 | |||
| Daniel Scott Currie | Chief Operating Officer | Feb 1, 2024 | |||
| Edward R. Uzialko | Director | Jul 12, 2024 | |||
| Alistair Milnes | Director | Jul 12, 2024 | |||
| Richard D. Spector | Chief Commercial Officer | Feb 12, 2024 | |||
| PharmaCyte Biotech, Inc. | 10%+ Owner | Nov 21, 2023 | |||
| Joshua Silverman | Director | Jul 12, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|